Biotechnology Future Investment Expansion Act of 2005
Latest action · Oct 19, 2005 Referred to the House Committee on Ways and Means.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedOct 19, 2005
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Biotechnology Future Investment Expansion Act of 2005 - Amends the Internal Revenue Code to permit certain biomedical research corporations to engage in investments and other transactions involving shifts in ownership without incurring limitations on net operating loss carryforwards and certain built-in losses.
Cosponsors 9
Members who signed on, in the order they did. Signatures ran from Oct 19, 2005 to Apr 27, 2006; 5 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-AZ | J. D. Hayworth | Original | Oct 19, 2005 |
| R-PA | Jim Gerlach | Original | Oct 19, 2005 |
| R-PA | Phil English | Original | Oct 19, 2005 |
| D-MA | Richard E. Neal | Original | Oct 19, 2005 |
| R-NY | Thomas M. Reynolds | Original | Oct 19, 2005 |
| R-KY | Ron Lewis | Nov 10, 2005 | |
| R-CA | Wally Herger | Nov 10, 2005 | |
| D-MD | C. A. Dutch Ruppersberger | Dec 15, 2005 | |
| D-NJ | Rush Holt | Apr 27, 2006 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Ways and Means Committee | Referred Oct 19, 2005 |
Actions 2
Everything that happened, newest first.
- Oct 19, 2005Introduced in House
- Oct 19, 2005Referred to the House Committee on Ways and Means.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 1893 | Biotechnology Future Investment Expansion Act of 2005 | Identical bill | Oct 19, 2005 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To permit biomedical research corporations to engage in certain financings and other transactions without incurring limitations on net operating loss carryforwards and certain built-in losses, and for other purposes.
- Short Titles as Introduced
- Biotechnology Future Investment Expansion Act of 2005
Subjects
Assigned by the Library of Congress. Policy area: Taxation.
- Accounting
- Biotechnology
- Capital gains tax
- Clinical trials
- Commerce
- Corporate debt
- Corporate finance
- Corporate mergers
- Corporate reorganizations
- Corporation taxes
- Drug industry
- Finance and Financial Sector
- Health
- Income tax
- Investments
- Losses
- Pharmaceutical research
- Science, Technology, Communications
- Tax credits
- Tax exclusion
- Tax incentives
- Taxation
Text 1
Each version as it was printed, newest first.
- Oct 19, 2005Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.